Wang Wen-jun, Zhou Jiang-nan, Cao Sheng-jun
Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, China.
Hunan Yi Ke Da Xue Xue Bao. 2002 Dec 28;27(6):547-50.
To study the clinical value of interbody cage systems in the surgical treatment of unstable lumbar segment, and evaluate the biomechanical properties.
Ninety-seven cases were selected for operation by posterior lumbar interbody fusion with the BAK-cage or TFC device. Of the patients, 18 were diagnosed as lumbar disc degeneration disease (DDD), 37 as lumbar stenosis, 23 as spondylolisthesis, and 19 as unstable traumatic lesion. Thirty-six of them received additional posterior pedicle devices; 13 cases with severe mechanical back pain underwent anterior interbody fusion with the BAK-cage or TFC or interbod spacer, 4 of them underwent surgery once again. A new anterior Mesh-cage was used in spinal reconstruction for some patients, including 8 patients with thoracolumbar tumor, 2 with lumbar burst fracture, and 1 with osteoportic late collapse of a vertebral body.
In the follow-up for an average of 21 months, 63 patients were available for review. The clinical results were excellent and good in 91.2% of the patients who underwent posterior interbody cage fusion; the preoperative percentage of slip was corrected in 89% of the patients with spondlyolithsis and in 100% of the patients with traumatic dislocation. The satisfactory rate was 94.6% in the patients with severe back pain who underwent anterior interbody cage fusion. The rate of union in the grafted area was 95% at the 6th month after the operation. A preliminary experience showed that the clinical effect was obvious as the Mesh-cage was used in the patients with tumor, symptoms were relieved and motion ability was greatly improved in these patients.
The interbody cage implant produces immediate stabilisation on unstable spinal segments, offers a conductive biomechanical environment for interbody graft healing by distraction properties and weight bearing function, and restores the normal interbody space and spinal column lordosis with satisfactory clinical effects on such diseases as DDD, traumatic lesion, osteoporotic late collapse of a vertebral body and spinal tumors.
研究椎间融合器系统在不稳定腰椎节段手术治疗中的临床价值,并评估其生物力学特性。
选取97例行后路腰椎椎间融合术并使用BAK椎间融合器或TFC装置的患者。其中,18例诊断为腰椎间盘退变疾病(DDD),37例为腰椎管狭窄症,23例为椎体滑脱,19例为不稳定创伤性损伤。其中36例患者加用后路椎弓根内固定装置;13例机械性背痛严重的患者接受了前路椎间融合术,使用BAK椎间融合器、TFC或椎间融合器,其中4例再次接受手术。部分患者在脊柱重建中使用了新型前路Mesh椎间融合器,包括8例胸腰椎肿瘤患者、2例腰椎爆裂骨折患者和1例骨质疏松性椎体晚期塌陷患者。
平均随访21个月,63例患者可供复查。后路椎间融合器融合的患者中,91.2%的临床效果为优或良;椎体滑脱患者中89%的术前滑脱百分比得到矫正,创伤性脱位患者中100%得到矫正。前路椎间融合器融合的严重背痛患者的满意率为94.6%。术后6个月植骨区融合率为95%。初步经验表明,Mesh椎间融合器应用于肿瘤患者临床效果明显,患者症状缓解,活动能力显著改善。
椎间融合器植入物可立即稳定不稳定的脊柱节段,通过撑开特性和承重功能为椎间植骨愈合提供有利的生物力学环境,并恢复正常的椎间间隙和脊柱前凸,对DDD、创伤性损伤、骨质疏松性椎体晚期塌陷和脊柱肿瘤等疾病具有满意的临床效果。